Literature DB >> 15741018

Implications of post-gadolinium MRI results in 13 cases with posterior reversible encephalopathy syndrome.

Mehmet Sahin Ugurel1, Minako Hayakawa.   

Abstract

BACKGROUND: There is a relative lack of definitive information about the contrast-enhancement characteristics of lesions in posterior reversible encephalopathy syndrome (PRES).
OBJECTIVE: Evaluation of contrast-enhanced MRI findings in PRES with a special emphasis on pathophysiology of post-gadolinium behavior of these lesions.
MATERIALS AND METHODS: Contrast-enhanced 1.5 T MRI findings and relevant clinical data of the patients were retrospectively reviewed on 13 cases (six males, seven females; age range: 22-78; mean age 47). Although fluid attenuated inversion recovery (FLAIR) and diffusion-weighted MR images were considered for identification of the entity, primarily post-contrast T1-weighted MR images were searched for traces of enhancement in the lesions.
RESULTS: No definitely enhancing lesion was identified in the MR images obtained in 6-48 h after onset of symptoms (mostly headaches, seizures and cortical visual field deficits) in this series. Severity of disease indicated by small hemorrhages, confluence of lesions or progression to cytotoxic edema did not seem to alter this result. Typical lesion characteristics were consistent with vasogenic edema on FLAIR and diffusion MR images. Acute elevation of blood pressure on chronic hypertensive background was responsible in four, eclampsia in three, uremia with blood pressure fluctuations in three, and cyclosporine-toxicity in three cases.
CONCLUSION: Although occasional enhancing brain lesions have been reported in the literature on PRES, contrast-enhancement of lesions may be a factor of scan timing and underlying etiology. Prospective studies with larger series on PRES are required for better evaluation of contrast-enhancement in MRI with respect to scan timing, which in turn may help understand its pathophysiology better.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15741018     DOI: 10.1016/j.ejrad.2004.05.015

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  6 in total

1.  Posterior reversible encephalopathy syndrome caused by hypertensive encephalopathy and acute uremia.

Authors:  Mustafa Gokce; Ekrem Dogan; Saadet Nacitarhan; Gulen Demirpolat
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

2.  Medication neurotoxicity in children.

Authors:  Ramesh S Iyer; Apeksha Chaturvedi; Sumit Pruthi; Paritosh C Khanna; Gisele E Ishak
Journal:  Pediatr Radiol       Date:  2011-07-23

3.  Posterior Reversible Encephalopathy Syndrome: The Spectrum of MR Imaging Patterns.

Authors:  O Kastrup; M Schlamann; C Moenninghoff; M Forsting; S Goericke
Journal:  Clin Neuroradiol       Date:  2014-02-20       Impact factor: 3.649

4.  Utility and Significance of Gadolinium-Based Contrast Enhancement in Posterior Reversible Encephalopathy Syndrome.

Authors:  S J Karia; J B Rykken; Z J McKinney; L Zhang; A M McKinney
Journal:  AJNR Am J Neuroradiol       Date:  2015-11-12       Impact factor: 3.825

5.  Posterior reversible encephalopathy syndrome in the pediatric renal population.

Authors:  Ali Mirza Onder; Robert Lopez; Uygar Teomete; Denise Francoeur; Rita Bhatia; Obioma Knowbi; Rana Hizaji; Jayanthi Chandar; Carolyn Abitbol; Gaston Zilleruelo
Journal:  Pediatr Nephrol       Date:  2007-08-11       Impact factor: 3.714

6.  Delayed Posterior Reversible Leukoencephalopathy Syndrome Triggered by FLOT Chemotherapy.

Authors:  Jordi Gandini; Mario Manto; Nicolas Charette
Journal:  Front Neurol       Date:  2020-01-30       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.